China NMPA Drug Inspection - Shangqiu Jinma Pharmaceutical Co., Ltd. - Infant Spleen-Strengthening Powder
China NMPA drug inspection for Shangqiu Jinma Pharmaceutical Co., Ltd. published September 21, 2020. Drug: Infant Spleen-Strengthening Powder. On September 21, 2020, the Jiangxi Provincial Drug Administration published its fourth inspection report of the year, id
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shangqiu Jinma Pharmaceutical Co., Ltd. published September 21, 2020. Drug: Infant Spleen-Strengthening Powder. On September 21, 2020, the Jiangxi Provincial Drug Administration published its fourth inspection report of the year, id
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox